eli lilly glp-1 dominance is selling $12.9 billion of drugs every three months — and expects to sell even more Lilly sees obesity drug leadership
Description
Laboratory and animal studies suggest GLP-1 receptor agonists may also inhibit nuclear factor-kappa B (NF-B) signaling, a key pathway in inflammatory gene expression, and reduce oxidative stress through enhanced antioxidant enzyme activity

Bariatric surgery can significantly alleviate T2DM and usually can substantially improve blood glucose levels prior to weight loss after surgery (Madsbad et al., 2014)
Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics

BMJ 372:n71 [DOI] [PMC free article] [PubMed] [Google Scholar] 18.Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials

JCI Insight (2020) 5(6):e133429
